Mark Redston

18.9k citations
115 papers · 13.1k · 4 hit papers · h-index 54

Impact in

    • Genetic factors in colorectal cancer
  • Oncology top 0.1%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Screening and Detection
    • Cancer-related Molecular Pathways

Papers in

    • Genetic factors in colorectal cancer 51
    • Colorectal Cancer Treatments and Studies 15
    • Pancreatic and Hepatic Oncology Research 15
    • Colorectal Cancer Screening and Detection 11
    • Cancer-related Molecular Pathways 7

Mark Redston

113 papers receiving 12.7k citations

Mark Redston's Hit Papers

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma 2003 · 812 citations
8120+10+21Years since publication50010001.5k

Peers

Mark Redston
Comparison fields: 5 of 120
  • Pathology and Forensic Medicine 5.1k
  • Oncology 6.9k
  • Cancer Research 2.9k
  • Molecular Biology 3.8k
  • Surgery 2.0k
Replace Jeremy R. Jass with:
Jeremy R. Jass Australia
G.J.A. Offerhaus Netherlands
Sabine Tejpar Belgium
Matthias Kloor Germany
Teresa A. Brentnall United States
Siu Tsan Yuen Hong Kong
Frédéric Bibeau France
Christophe Rosty Australia
Barry Iacopetta Australia
Hans Morreau Netherlands
Mark Redston relative to Jeremy R. Jass Australia Jeremy R. Jass's profile →
Citations per field
00.5×1.5×
Jeremy R. Jass · 1×
Citations per year

Countries citing papers authored by Mark Redston

Since Specialization
Citations

This map shows the geographic impact of Mark Redston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Redston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Redston more than expected).

Fields of papers citing papers by Mark Redston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Redston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Redston. The network helps show where Mark Redston may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Redston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Redston Line = papers co-authored together Mark Redston links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
Hit paper breakdown →
20031693
2
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Hit paper breakdown →
20001129
3
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Hit paper breakdown →
1994961
4
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma
Hit paper breakdown →
2003812
5 2002459
6 2006436
7
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.
1994380
8 1995341
9 2006317
10 2008301
11 2005298
12 2009290
13
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
1999221
14 2004216
15 1999211
16 2004203
17 2000201
18
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
2000191
19
Allelotype of pancreatic adenocarcinoma.
1994186
20 1997160

About Mark Redston

Mark Redston is a scholar working on Pathology and Forensic Medicine, Oncology, Surgery, Cancer Research and Molecular Biology, having authored 115 papers that have together received 13.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (51 papers), Cancer Genomics and Diagnostics (24 papers), Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (15 papers), Colorectal Cancer Screening and Detection (11 papers), Colorectal and Anal Carcinomas (7 papers), Cancer-related Molecular Pathways (7 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (5.1k citations), Oncology (6.9k citations), Cancer Research (2.9k citations), Molecular Biology (3.8k citations) and Surgery (2.0k citations). Mark Redston has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Steven Gallinger, Robert Gryfe, Carlos Caldas, Ralph H. Hruban, Richard M. Goldberg, Albert Seymour, Hyeja Kim, Eric J. Holowaty, Bharati Bapat and Melyssa Aronson. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology, The American Journal of Surgical Pathology, Cancer Research and Diseases of the Colon & Rectum.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact